Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetInterleukin-2
LigandBDBM387270
Substrate/Competitorn/a
Meas. Tech.Inhibition of IL-2 secretion
IC50<100.0±n/a nM
Citation Irlapati, NRDeshmukh, GKKarche, VPJachak, SMSinha, NPalle, VPKamboj, RK Oxazoline and isoxazoline derivatives as CRAC modulators US Patent US10292981 Publication Date 5/21/2019
More Info.:Get all data from this article,  Assay Method
 
Interleukin-2
Name:Interleukin-2
Synonyms:IL-2 | IL2 | IL2_HUMAN | INN=Aldesleukin | Interleukin-2 | Interleukin-2 (IL-2) | T-cell growth factor | TCGF
Type:Enzyme
Mol. Mass.:17630.05
Organism:Homo sapiens (Human)
Description:P60568
Residue:153
Sequence:
MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRML
TFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSE
TTFMCEYADETATIVEFLNRWITFCQSIISTLT
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM387270
n/a
NameBDBM387270
Synonyms:2,6- Difluoro-N-(5-(2- methyl-5-(4- methyl-5-oxo-4,5- dihydro-1,3,4- oxadiazol-2- yl)phenyl)pyrazin- 2-yl)benzamide | US10292981, Example 87
TypeSmall organic molecule
Emp. Form.C21H15F2N5O3
Mol. Mass.423.3723
SMILESCc1ccc(cc1-c1cnc(NC(=O)c2c(F)cccc2F)cn1)-c1nn(C)c(=O)o1
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: